Intelligent Bio Solutions Inc.
INBS Nasdaq
SEC CIK 1725430
Follow Intelligent Bio Solutions
Weekly email: filings, results
Revenue, last quarter
$1.4M
+25.2% vs same quarter last year
Net income
−$2.7M
+10.9% vs same quarter last year
EPS, diluted
−$0.86
+75.4% vs same quarter last year
Operating cash flow
−$2.8M
+3.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $4.2M | −$12.5M |
| FY25 | $3.1M | −$10.6M |
| FY24 | $3.1M | −$10.2M |
| FY23 | $1.3M | −$10.6M |
| FY22 | $437.1K | −$8.3M |
| FY21 | $2M | −$7M |
| FY20 | $188.7K | −$3.2M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 48.6% | −299.1% | −295.8% |
| FY25 | 40.8% | −349.8% | −347.4% |
| FY24 | 45.8% | −330.5% | −327.5% |
| FY23 | 26% | −1002.1% | −845.9% |
| FY22 | - | −1907.1% | −1900.1% |
| FY21 | - | −281.4% | −355.3% |
| FY20 | - | −1513.7% | −1676.2% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | −$12.1M |
| FY25 | −$9.9M |
| FY24 | −$9.8M |
| FY23 | - |
| FY22 | - |
| FY21 | - |
| FY20 | - |
| FY19 | - |
- Intelligent Bio Solutions
- Healthcare median
Show the numbers
| Year | Intelligent Bio Solutions | Healthcare median |
|---|---|---|
| FY26 | −295.8% | −11.1% |
| FY25 | −347.4% | −30.6% |
| FY24 | −327.5% | −47% |
| FY23 | −845.9% | −58% |
| FY22 | −1900.1% | −80.4% |
| FY21 | −355.3% | −71.8% |
| FY20 | −1676.2% | −62.2% |
| FY19 | - | −46.2% |